Center-Authored Papers

Filters: Keyword is Positron-Emission Tomography  [Clear All Filters]
B
Bartel TB, Haessler J, Brown TLY, Shaughnessy JD, van Rhee F, Anaissie E, Alpe T, Angtuaco E, Walker R, Epstein J et al..  2009.  F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma.. Blood. 114(10):2068-76. Abstract
van den Bent MJ, Wefel JS, Schiff D, Taphoorn MJB, Jaeckle K, Junck L, Armstrong T, Choucair A, Waldman AD, Gorlia T et al..  2011.  Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.. The lancet oncology. 12(6):583-93. Abstract
C
Carr LL, Mankoff DA, Goulart BH, Eaton KD, Capell PT, Kell EM, Bauman JE, Martins RG.  2010.  Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(21):5260-8. Abstract
Chamberlain MC, Eaton KD, Fink JR, Tredway T.  2010.  Intradural intramedullary spinal cord metastasis due to mesothelioma.. Journal of neuro-oncology. 97(1):133-6. Abstract
D
Doot RK, Muzi M, Peterson LM, Schubert EK, Gralow JR, Specht JM, Mankoff DA.  2010.  Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 51(4):521-7. Abstract
Dunnwald LK, Gralow JR, Ellis GK, Livingston RB, Linden HM, Specht JM, Doot RK, Lawton TJ, Barlow WE, Kurland BF et al..  2008.  Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(27):4449-57. Abstract
Dunnwald LK, Doot RK, Specht JM, Gralow JR, Ellis GK, Livingston RB, Linden HM, Gadi VK, Kurland BF, Schubert EK et al..  2011.  PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(8):2400-9. Abstract
E
Eby PR, Partridge SC, White SW, Doot RK, Dunnwald LK, Schubert EK, Kurland BF, Lehman CD, Mankoff DA.  2008.  Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer.. Academic radiology. 15(10):1246-54. Abstract
F
Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, Coleman ER, Wahl R, Paschold JC, Avril N et al..  2008.  Recommendations on the use of 18F-FDG PET in oncology.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 49(3):480-508. Abstract
J
Jhaveri K, Linden H.  2015.  Measuring tumor metabolism by 18F-FDG PET predicts outcome in a multicenter study: a step off in the right direction.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 56(1):1-2.
L
Linden HM, Kurland BF, Peterson LM, Schubert EK, Gralow JR, Specht JM, Ellis GK, Lawton TJ, Livingston RB, Petra PH et al..  2011.  Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(14):4799-805. Abstract
M
Mankoff DA, Specht JM, Eubank WB, Kessler L.  2012.  [¹⁸F]fluorodeoxyglucose positron emission tomography-computed tomography in breast cancer: when... and when not? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(12):1252-4.
P
Partridge SC, Vanantwerp RK, Doot RK, Chai X, Kurland BF, Eby PR, Specht JM, Dunnwald LK, Schubert EK, Lehman CD et al..  2010.  Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer.. Journal of magnetic resonance imaging : JMRI. 32(5):1124-31. Abstract
Peterson LM, Kurland BF, Link JM, Schubert EK, Stekhova S, Linden HM, Mankoff DA.  2011.  Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer.. Nuclear medicine and biology. 38(7):969-78. Abstract
S
Schnipper LE, Lyman GH, Blayney DW, Hoverman RJ, Raghavan D, Wollins DS, Schilsky RL.  2013.  American Society of Clinical Oncology 2013 top five list in oncology.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(34):4362-70.
Smith SD, Redman M, Dunleavy K.  2015.  FDG PET-CT in follicular lymphoma: a case-based evidence review.. Blood. 125(7):1078-82. Abstract
Specht JM, Mankoff DA.  2012.  Advances in molecular imaging for breast cancer detection and characterization.. Breast cancer research : BCR. 14(2):206. Abstract
Specht JM, Kurland BF, Montgomery SK, Dunnwald LK, Doot RK, Gralow JR, Ellis GK, Linden HM, Livingston RB, Allison KH et al..  2010.  Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(10):2803-10. Abstract
T
Tsimberidou A-M, Kantarjian HM, Wen S, O'Brien S, Cortes J, Wierda WG, Koller C, Pierce S, Brandt M, Freireich EJ et al..  2008.  The prognostic significance of serum beta2 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1,180 patients.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(3):721-30. Abstract
Y
Yu EY, Muzi M, Hackenbracht JA, Rezvani BB, Link JM, Montgomery RB, Higano CS, Eary JF, Mankoff DA.  2011.  C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.. Clinical nuclear medicine. 36(3):192-8. Abstract
Yu EY, Duan F, Muzi M, Deng X, Chin BB, Alumkal JJ, Taplin M-E, Taub JM, Herman B, Higano CS et al..  2015.  Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: results from American College of Radiology Imaging Network 6687.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 56(3):354-60. Abstract